FDA guidance for next generation sequencing-based testing: balancing regulation and innovation in precision medicine
NPJ Genom Med
.
2018 Oct 3:3:28.
doi: 10.1038/s41525-018-0067-2.
eCollection 2018.
Authors
Frank Luh
1
,
Yun Yen
2
Affiliations
1
Sino-American Cancer Foundation, Temple City, CA USA.
2
2PhD Program of Cancer Biology and Drug Discovery, TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan.
PMID:
30302274
PMCID:
PMC6170456
DOI:
10.1038/s41525-018-0067-2
No abstract available